Non-tuberculous Mycobacterium Infection Associated with Artificial Stone Silicosis: A Case Series

Shimon Izhakian1, Lena Slobodscoy Ignatov1, Alon Gorenshtein1

  • 1Pulmonary Institute, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.

Abstract

Insights

Non-tuberculous mycobacterium (NTM) infections may occur in patients with artificial stone silicosis, presenting with respiratory symptoms and characteristic lung changes. Early diagnosis and microbiological evaluation are crucial for managing these challenging infections.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Occupational Health

Background:

  • Rising incidence of non-tuberculous mycobacterium (NTM) infections in chronic lung diseases.
  • NTM infections pose significant morbidity and mortality challenges.
  • NTM in natural stone silicosis is known, but unexplored in artificial stone silicosis.

Purpose of the Study:

  • Describe clinical, radiological, and pathological features of NTM infections in artificial stone silicosis.
  • Emphasize the importance of early diagnosis for NTM in this patient group.

Main Methods:

  • Retrospective review of a tertiary medical center database (2010-2024).
  • Identification of patients with occupational artificial stone silicosis and NTM infection.

Main Results:

  • Eight male patients (42-74 years) with artificial stone silicosis and NTM infection identified.
  • Symptoms included dyspnea, cough, weight loss, fever; CT showed lymphadenopathy, fibrosis, cavitations, etc.
  • Biopsies revealed silicotic nodules, crystals, silico-proteinosis, fibrosis; 4 died, 6 needed lung transplant.

Conclusions:

  • Artificial stone silicosis is potentially associated with NTM infections.
  • High clinical suspicion is vital for early diagnosis.
  • Worsening symptoms in silicosis patients warrant microbiological evaluation (sputum culture, BAL).

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
801
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
884
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
467
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
520